Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

ClinicalTrials.gov ID: NCT00227318

Public ClinicalTrials.gov record NCT00227318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 6:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter, Long-term Trial of Preventing Hypertension Using Candesartan Cilexetil 16 mg in Patients With High Normal Blood Pressure (TROPHY)

Study identification

NCT ID
NCT00227318
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,000 participants

Conditions and interventions

Conditions

Interventions

  • ATACAND Drug

Drug

Eligibility (public fields only)

Age range
30 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 1998
Primary completion
Sep 30, 2005
Completion
Sep 30, 2005
Last update posted
Aug 29, 2011

1998 – 2005

United States locations

U.S. sites
42
U.S. states
24
U.S. cities
42
Facility City State ZIP Site status
Research Site Mobile Alabama
Research Site Long Beach California
Research Site Redondo Beach California
Research Site Santa Ana California
Research Site Tustin California
Research Site Wilmington Delaware
Research Site Washington D.C. District of Columbia
Research Site Bay Pines Florida
Research Site Gainsville Florida
Research Site Ocala Florida
Research Site Chicago Illinois
Research Site Shawnee Mission Kansas
Research Site Chelsea Michigan
Research Site Detroit Michigan
Research Site Minneapolis Minnesota
Research Site Jackson Mississippi
Research Site Florissant Missouri
Research Site Kansas City Missouri
Research Site St Louis Missouri
Research Site Buffalo New York
Research Site Rochester New York
Research Site Williamsville New York
Research Site Asheville North Carolina
Research Site Chapel Hill North Carolina
Research Site Winston-Salem North Carolina
Research Site Fargo North Dakota
Research Site Canton Ohio
Research Site Cleveland Ohio
Research Site Columbus Ohio
Research Site Oklahoma City Oklahoma
Research Site Allentown Pennsylvania
Research Site Fleetwood Pennsylvania
Research Site Pittsburgh Pennsylvania
Research Site Providence Rhode Island
Research Site Warwick Rhode Island
Research Site Charleston South Carolina
Research Site Memphis Tennessee
Research Site Dallas Texas
Research Site Houston Texas
Research Site Richmond Virginia
Research Site Morgantown West Virginia
Research Site Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00227318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 29, 2011 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00227318 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →